A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination
KeywordsCovishield, Guillain-Barré syndrome, GBS, AstraZeneca, Coronavirus, pandemic, vaccine, ChAdOx1
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.
Issue: 2021: Vol 8 No 9 (view)